Document ID: chunk:federal_register_of_legislation:F2025L00049:schedule:10:p1
Version: federal_register_of_legislation:F2025L00049
Segment Type: schedule
Provision Reference: sch 10 (pt 1/4)
Character Range: 442312–445599

Schedule 10—Substances of such danger to health as to warrant prohibition of supply and use

Note 1: See subsection 57(2) and section 63.
Note 2: Schedule 10 contains substances previously included in Appendix C.
ABRUS PRECATORIUS (Jequirity) seed or root for therapeutic use.
ACORUS CALAMUS (calamus) for human therapeutic use.
ALKALINE SALTS, being the carbonate, silicate or phosphate salts of sodium or potassium alone or in any combination for domestic use:

       (a) in liquid or semi‑solid food additive preparations, tHE pH of which is more than 11.5; or

       (b) in solid automatic dishwashing preparations, tHE pH of which in a 500 g/L aqueous solution or mixture is more than 12.5; or

       (c) in liquid or semi‑solid automatic dishwashing preparations, tHE pH of which is more than 12.5.
ALKYLAMINES WITH STIMULANT PROPERTIES except when separately specified in these schedules.
2‑AMINO‑5‑METHYLPHENOL in preparations for cosmetic use.
AMINOPHENAZONE (amidopyrine) and its derivatives for human therapeutic use.
AMYGDALIN for therapeutic use.
ANCHUSA OFFICINALIS for therapeutic use.
o‑ANISIDINE (excluding derivatives) in preparations for skin colouration (including tattooing) and dyeing of hair, eyelashes or eyebrows except in preparations containing 0.001% or less of o‑anisidine.
APRONAL for therapeutic use.
ARISTOLOCHIA spp. for therapeutic use.
ARISTOLOCHIC ACID(S) for human therapeutic use.
ASARUM spp. containing aristolochic acid(s) for human therapeutic use.
AZADIRACHTA INDICA (neem) including its extracts and derivatives, in preparations for human internal use except "debitterised neem seed oil".
BASIC ORANGE 31 (2‑[(4‑aminophenyl)azo]‑1,3‑dimethyl‑1H‑imidazolium chloride) in preparations for skin colouration and dyeing of eyelashes or eyebrows.
1,2‑BENZENEDIAMINE in preparations for cosmetic use and skin colouration (including tattooing).
1,3‑BENZENEDIAMINE in preparations for cosmetic use and skin colouration (including tattooing).
BITHIONOL for human therapeutic use.
BORAGO OFFICINALIS (Borage) for therapeutic use except the fixed oil derived from the seeds of Borago officinalis.
BRAGANTIA spp. containing aristolochic acid(s) for human therapeutic use.
BUCLOSAMIDE for therapeutic use.
BUNIODYL SODIUM for therapeutic use.
1,4‑BUTANEDIOL (excluding its derivatives) in non‑polymerised form in preparations for domestic use.
BUTYL BENZYL PHTHALATE for cosmetic use.
CACALIA spp. for therapeutic use.
CARBAMIDE PEROXIDE (excluding its salts and derivatives) in teeth whitening preparations containing more than 18% of carbamide peroxide except in preparations manufactured for, and supplied solely by, registered dental practitioners as part of their dental practice.
CARDARINE.
CHRYSOIDINE BASE in preparations for use in hair dyes.
CINCHOPHEN and its derivatives for therapeutic use.
CLIOQUINOL and other halogenated derivatives of oxyquinoline for human internal use except or when being used solely for experimental purposes in humans and where such use:

       (a) is in accordance with:

          (i) an approval granted under paragraph 19(1)(b) of the Act, including any conditions specified in the notice of approval; and

          (ii) any conditions specified in the Therapeutic Goods Regulations 1990 for the purposes of